Top Markets
#1 Black Phoenix Black Phoenix +736.30%
#2 FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock) +24.93%
#3 Wrapped STX (Velar) Wrapped STX (Velar) +17.76%
#4 MetaDAO MetaDAO +16.19%
#5 Verus Coin Verus Coin +13.95%
#6 Akedo Akedo +10.21%
#7 PondCoin PondCoin +6.99%
#8 wojak wojak +6.93%
#9 Quack AI Quack AI +6.35%
#10 MiL.k Alliance MiL.k Alliance +6.08%
Coin of the day
Black Phoenix Black Phoenix
Settings
Language
ENGLISH
Currency
USD
Theme
Hebei Changshan Biochemical Pharmaceutical Co., Ltd. Hebei Changshan Biochemical Pharmaceutical Co., Ltd.

Hebei Changshan Biochemical Pharmaceutical Co., Ltd.

300255
Rank in Stocks #4908
Hebei Changshan Biochemical Pharmaceutical Co., Ltd. operates within China,... Hebei Changshan Biochemical Pharmaceutical Co., Ltd. operates within China, focusing on the entire lifecycle of heparin-based pharmaceuticals – from their initial research and development to manufacturing and sales. Their products are primarily utilized for the treatment of cardiovascular and cerebrovascular diseases. The company offers a broad range of heparin compounds, including crude heparin sodium and refined heparin sodium raw materials. Their portfolio also features a variety of injectable heparin preparations, such as standard heparin sodium injections. Furthermore, they produce both the raw materials and finished injectable forms for several low molecular weight heparins, specifically low molecular weight heparin calcium, enoxaparin sodium, nadroparin calcium, and dalteparin sodium. Established in the year 2000, Hebei Changshan Biochemical Pharmaceutical Co., Ltd. is headquartered in Shijiazhuang, China.
Share Price
$3.46
Last synced: 2026-08-26
Market Cap
$3.18B
Change (1 day)
-0.87%
Change (1 year)
-51.34%
Country
CN
Trade Hebei Changshan Biochemical Pharmaceutical Co., Ltd. (300255)

Category

Healthcare
Earnings for Hebei Changshan Biochemical Pharmaceutical Co., Ltd. (300255)
Earnings in 2026 TTM: 0
According to Hebei Changshan Biochemical Pharmaceutical Co., Ltd. latest financial reports the company's current earnings are 0. In 2026 the company made an earning of 0, equal to its 2026 earnings that were of 0. The earnings displayed on this page are the earnings before interest and taxes or simply EBIT.
Earnings history for Hebei Changshan Biochemical Pharmaceutical Co., Ltd. from 2026 to 2026
Earnings at the end of each year
Year Earnings Change
Not enough data for the provided dates.
Earnings for similar companies or competitors
Company Earnings Earnings Difference Country
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
$5.27B -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
$1.95B -
NL
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
$-3.09B -
US
CSL Limited CSL Limited
CSL Limited
CSL.AX
$-4.02B -
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
- -
CH